Fidaxomicin
FDA Approved: * January 16, 2024Pharm Company: * ACTAVIS LABS FL
Category: Antibiotics
Fidaxomicin, sold under the brand name Dificid among others, is the first member of a class of narrow spectrum macrocyclic antibiotic drugs called tiacumicins.[3] It is a fermentation product obtained from the actinomycete Dactylosporangium aurantiacum subspecies hamdenesis.[4][5] Fidaxomicin is minimally absorbed into the bloodstream when taken orally, is bactericidal, and selectively eradicates pathogenic Clostridioides difficile with relati... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion